Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Nov;20(11):1545-51.
doi: 10.1007/s00467-005-2015-5. Epub 2005 Aug 16.

Nitric oxide modulates renal vasoconstrictor effect of endothelin-1 in conscious lambs

Affiliations

Nitric oxide modulates renal vasoconstrictor effect of endothelin-1 in conscious lambs

Francine G Smith et al. Pediatr Nephrol. 2005 Nov.

Abstract

To test the hypothesis that nitric oxide (NO) buffers the renal vasoconstrictor effects of endothelin-1 (ET-1) early in life, renal haemodynamic responses to ET-1 were measured in the presence and absence of endogenously produced NO in conscious lambs. Renal haemodynamic effects of ET-1 were measured for 5 min before (control) and 20 min after intraarterial injection of ET-1 before and after pretreatment with 20 mg/kg of the L-arginine analogue N(G)-nitro-L-arginine methyl ester (L-NAME), (experiment 1) and its inactive isomer D-NAME (experiment 2) in conscious lambs aged approximately 1 week (N=7) and approximately 6 weeks (N=6). The two experiments were carried out in random order at intervals of 24-48 h. In lambs aged approximately 6 weeks, a marked increase in renal vascular resistance (RVR) was elicited by ET-1 administration; this response was enhanced twofold following pretreatment with L-NAME. In 1-week-old lambs, however, an increase in RVR in response to ET-1 occurred only after pretreatment with L-NAME. Therefore, we accept our hypothesis and conclude that NO buffers the renal vasoconstrictor effects of ET-1 early in life.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Naunyn Schmiedebergs Arch Pharmacol. 1996 Nov;354(5):572-8 - PubMed
    1. Eur J Pharmacol. 1989 Nov 21;171(2-3):237-40 - PubMed
    1. Br J Clin Pharmacol. 1997 Jul;44(1):9-20 - PubMed
    1. Mech Ageing Dev. 1997 Apr;95(1-2):143-52 - PubMed
    1. J Clin Invest. 1989 Jan;83(1):317-20 - PubMed

Publication types

LinkOut - more resources